Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments.
Fukuda Denshi Co's 3-Year RORE % for the quarter that ended in Mar. 2026 was 1.76%.
The industry rank for Fukuda Denshi Co's 3-Year RORE % or its related term are showing as below:
FKDSF's 3-Year RORE % is ranked better than 55.24% of 782
companies
in the Medical Devices & Instruments industry
Industry Median: -4.31
vs FKDSF: 1.76
Fukuda Denshi Co (OTCPK:FKDSF) 3-Year RORE % Explanation
Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.
There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.
Be Aware
Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.
Fukuda Denshi Co 3-Year RORE % Related Terms
Fukuda Denshi Co 3-Year RORE % Historical Data
* Premium members only.
The historical data trend for Fukuda Denshi Co's 3-Year RORE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Fukuda Denshi Co's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fukuda Denshi Co 3-Year RORE % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Fukuda Denshi Co's 3-Year RORE % distribution charts can be found below:
* The bar in red indicates where Fukuda Denshi Co's 3-Year RORE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Mar. 2026 and 3-year before.
Fukuda Denshi Co (FKDSF) has a 3-Year RORE % of 1.76 as of Mar. 2026. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Fukuda Denshi Co and its competitors. According to the industry distribution chart, Fukuda Denshi Co ranks #350 out of 782 companies in the Medical Devices & Instruments industry, placing it in the top 44.8%.
Is Fukuda Denshi Co's 3-Year RORE % too high?
Fukuda Denshi Co's current 3-Year RORE % is 1.76. Based on the distribution chart, Fukuda Denshi Co ranks #350 out of 782 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Fukuda Denshi Co has a GF Score™ of 83/100, reflecting its overall financial health beyond just this single metric.
How does Fukuda Denshi Co's 3-Year RORE % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Fukuda Denshi Co ranks #350 out of 782 companies for 3-Year RORE %. This puts Fukuda Denshi Co in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Medical Devices & Instruments company?
A good 3-Year RORE % depends on the Medical Devices & Instruments industry context. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Fukuda Denshi Co and its competitors. Fukuda Denshi Co's current 3-Year RORE % is 1.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fukuda Denshi Co stock overvalued right now?
Fukuda Denshi Co (FKDSF) has a current 3-Year RORE % of 1.76. The stock's GF Value™ is $27.75, compared to a current price of $42.55 — trading 53.3% above its estimated fair value. The current 3-Year RORE % is 1.76. Fukuda Denshi Co's overall GF Score™ is 83/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For Fukuda Denshi Co (FKDSF), the current 3-Year RORE % is 1.76 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fukuda Denshi Co (FKDSF) Overvalued in 2026?
Based on GuruFocus' analysis, Fukuda Denshi Co stock appears to be overvalued.
The current stock price of $42.55 is trading 53.3% above its estimated GF Value™ of $27.75.
Key valuation signals for FKDSF:
3-Year RORE %: 1.76
GF Value™: $27.75 vs. price of $42.55 (53.3% above fair value)
No single metric tells the full story. See the FKDSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fukuda Denshi Co Ltd develops and manufactures medical electronic equipment. The firm operates in four segments: physiological diagnostic equipment, patient monitoring equipment, medical treatment equipment, and consumables and other products. The physiological diagnostic equipment business sells electrocardiographs, vascular screening systems, and blood cell counters. The patient monitoring equipment segment sells patient monitors and transmitters. The medical treatment equipment segment contributes the largest proportion of revenue and sells pacemakers and medical equipment for home treatment. The consumables and other products segment sells disposable electrodes and consumables used for the firm's devices. Fukuda Denshi generates the vast majority of its sales in Japan.
83GF Score
Get the complete analysis for FKDSF
3-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FKDSF has been successfully added to your 
